Tumor-Derived Complement C3 Overexpression in STK11 -Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance

Cancer Immunology Research · Published 2026-04-28 · DOI 10.1158/2326-6066.cir-25-0534

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1158/2326-6066.cir-25-0534

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles